Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Recruiting · NCT05964504 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of California, San Francisco
View the official record on ClinicalTrials.gov →Interventions studied
Blood Specimen
What this trial is about
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
- Age \>=18 years
- Any receptor subtype.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion criteria
- Stage I-III breast cancer.
- Lack of lobular histology on tumor biopsy.
- Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Where it is running
4 locations listed across 3 US states.
- University of California, San Diego - San Diego, California, United States
- University of California, San Francisco - San Francisco, California, United States
- Abramson Cancer Center - Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center - Houston, Texas, United States